Simply and easily run your neuroimaging based clinical trial studies on our globally scalable cloud-based software platform.
Trial costs can reach millions of dollars with increasing complexity, difficulties in finding and retaining suitable patients and sites and constant delays.
Successful completion of a clinical trial can take years. On top of that, most trials experience delays of more than a month, which causes losses of valuable time and money.
Data from the United States shows that only 5.9% of phase I neurology clinical trial drugs are likely to get FDA approval and of the 2,352 neurology clinical trials started in 2020, fewer than 700 are still active.